Practice
Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report
Tyler Wilson, Rupi Brar, Christy Sutherland and Seonaid Nolan
CMAJ February 03, 2020 192 (5) E115-E117; DOI: https://doi.org/10.1503/cmaj.190732
Tyler Wilson
British Columbia Centre on Substance Use (Wilson, Brar, Sutherland, Nolan); Department of Medicine (Brar, Nolan, Sutherland), University of British Columbia, St. Paul’s Hospital, Vancouver, BC
MDRupi Brar
British Columbia Centre on Substance Use (Wilson, Brar, Sutherland, Nolan); Department of Medicine (Brar, Nolan, Sutherland), University of British Columbia, St. Paul’s Hospital, Vancouver, BC
MDChristy Sutherland
British Columbia Centre on Substance Use (Wilson, Brar, Sutherland, Nolan); Department of Medicine (Brar, Nolan, Sutherland), University of British Columbia, St. Paul’s Hospital, Vancouver, BC
MDSeonaid Nolan
British Columbia Centre on Substance Use (Wilson, Brar, Sutherland, Nolan); Department of Medicine (Brar, Nolan, Sutherland), University of British Columbia, St. Paul’s Hospital, Vancouver, BC
MD
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
Article tools
Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report
Tyler Wilson, Rupi Brar, Christy Sutherland, Seonaid Nolan
CMAJ Feb 2020, 192 (5) E115-E117; DOI: 10.1503/cmaj.190732
Jump to section
Related Articles
Cited By...
- No citing articles found.